All In MedTech

Device Trial Radar · NCT04515498

A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis

A Prospective Clinical Study of the Ability of the CloudCath System to Detect Peritonitis During In-home Peritoneal Dialysis

Last checked: Nov 19, 2026Latest source record: May 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

243

Actual

Start

Aug 19, 2020

Primary completion

Mar 31, 2023

Study completion Mar 31, 2023

Sponsor

Lead sponsor
CloudCathNot on our public-company list
Sponsor type
Industry
First posted
Aug 17, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to determine if the CloudCath device can detect infections related to peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by patients and doctors to detect such infections.

Conditions

  • Peritoneal Dialysis-associated Peritonitis

Interventions

  • CloudCath Monitoring SystemDevice

    The CloudCath Monitoring System will analyze effluent dialysate for changes associated with peritonitis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time of peritonitis detection (vs lab measures)Time frame: through 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CloudCath Investigational Site

    Lakewood, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.